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In natural environments, bacterial physiology is frequently characterized by slow
metabolic rates and complex cellular heterogeneities. The opportunistic pathogen
Pseudomonas aeruginosa provides one such example; P. aeruginosa forms untreat-
able chronic biofilm infections of the cystic fibrosis lung, where oxygen limitation
can lead to states of metabolic dormancy. To better understand the biology of
these states, in vitro experiments must be adapted to better recapitulate natural set-
tings. However, low rates of protein turnover and cellular or phenotypic complexity
make these systems di cult to study using established methods. Here we adapt
the bioorthogonal noncanonical amino acid tagging (BONCAT) method for time-
and cell-selective proteomic analysis to the study of P. aeruginosa. Analysis of
proteins synthesized in an anoxic dormancy state led to the discovery of a new
type of transcriptional regulator which we designated SutA. We performed detailed
analyses of SutA’s role in transcription under slow growth states and we elucidated
the structural basis for its regulatory behavior. Additionally, we used cell-selective
targeting of BONCAT labeling to determine the dynamic proteomic response of an
antibiotic-tolerant biofilm subpopulation to challenge with ciprofloxacin. Overall
this work shows the utility of selective proteomics as applied to bacterial physiology
and describes the broad biological insight obtained from that application.
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GFP. Green fluorescent protein.
ICD. Isocitrate dehydrogenase.
IP. Immunoprecipitation.
LC-MS/MS. Liquid chromatography-tandem mass spectrometry.
MIC. Minimum inhibitory concentration.
ncAA. Noncanonical amino acid.
RNAP. RNA polymerase.
ROS. Reactive oxygen species.
rRNA. Ribosomal RNA.
TAMRA. Tetramethylrhodamine.
TCA cycle. Tricarboxylic acid cycle.
UTR. Untranslated region.
1C h a p t e r 1
ADAPTING AND APPLYING BONCAT TO THE STUDY OF
PSEUDOMONAS AERUGINOSA PHYSIOLOGY
The overarching goal for my doctoral work was to adapt a method for selective
proteomic analysis toward the study of bacterial physiology. When I began this
e ort, the bioorthogonal noncanonical amino acid tagging (BONCAT) method for
proteome labeling and enrichment [1] had recently been modified to allow for cell-
selective analyses [2]. BONCAT relies on the cellular incorporation of a noncanon-
ical amino acid (ncAA) into nascent proteins. Proteins that contain the ncAA are
chemically distinct from the pre-existing proteome, and the presence of a functional
chemical handle on the ncAA (e.g., an azide) allows for selective chemical targeting
of these proteins via bioorothogonal chemistry (e.g., azide-alkyne cycloaddition).
Labeled proteins can be visualized in cells or lysates via reaction with a fluorescent
tag, or can be enriched via reaction with an a nity tag or solid support followed by
chromatography. Enriched proteins can then be identified and quantified by liquid
chromatography-tandem mass spectrometry (LC-MS/MS).
Temporal selectivity of protein labeling is achieved with a ncAA that is incorporated
bywild-type translationalmachinery (e.g.,  -azidohomoalanine, Aha) by controlling
when cells are exposed to the ncAA. Cell-selective protein labeling is achieved
through the use of a ncAA (e.g.,  -azidonorleucine, Anl) that is only incorporated
by cells that express a mutant aminoacyl-tRNA synthetase (mRS) engineered for
activity toward the ncAA. By restricting expression of the mRS to cell-types of
interest, BONCAT labeling can be targeted to particular cells present in complex,
heterogeneous mixtures.
Through the work of my colleagues and others, BONCAT has been established as a
powerful tool for studying nascent protein synthesis in a broad range of biological
contexts. For example, the method has been used to study localized translation in
mammalian neuronal cultures [3], newly synthesized proteins in mice [4], and to se-
lectively target tissues in Caenorhabditis elegans [5], and Drosophila melanogaster
[6]. In bacteria, time-selective labelingwith Aha has revealed the dynamic proteome
of Bacillus subtilis reviving from spores [7] and proteomics of the quorum sensing
response of Vibrio harveyi [8], while cell-selective approaches have been used to
2identify bacterial proteins important for host-cell infection [9, 10]. See Yuet and
Tirrell for a comprehensive review [11].
Because BONCAT o ers sensitive temporal and cellular selectivity, we thought it
would be particularly well suited to address questions of bacterial slow growth and
heterogeneity. Of particular interest was the opportunistic pathogen Pseudomonas
aeruginosa, a gram-negative bacterium whose infections of the cystic fibrosis (CF)
lung are chronic and recalcitrant to both the host immune system and to antimicrobial
therapies. These infections are characterized by bacteria in a dormant state with
low metabolic rates, a physiological condition known to contribute to antibiotic
tolerance. Additionally, P. aeruginosa grows as biofilm microcolonies within the
CF lung, a growth state inwhich nutrient gradients lead to phenotypic heterogeneities
that contribute further to tolerance. We set out to learn more about the physiology of
these states in vitro through selective proteomics. My contributions were twofold:
(i) the application of BONCAT to bacterial systems in which low metabolic rates
or cellular heterogeneity create di culties for traditional proteomic analyses and
(ii) the discovery and characterization of a new regulatory protein that helps P.
aeruginosa to adapt to these challenging conditions.
Chapter 2 describes the application of the BONCATmethod for temporally-selective
proteomic analysis. In this work, we determined the nascent proteome of P. aerug-
inosa subsisting in an anoxic survival state. Analysis of proteins preferentially
expressed in this state led to the discovery of a previously uncharacterized transcrip-
tion factor, which we now call SutA (survival under transitions). We found SutA
to be important for biofilm formation, the production of P. aeruginosa’s phenazine
virulence factors, and the organism’s ability to adapt to changing conditions. We
identified an interaction between SutA and RNA polymerase, and through this in-
teraction, its association with much of the chromosome. In particular, SutA shows
high levels of association with loci encoding ribosomal components (ribosomal
proteins and ribosomal RNA) and its presence in the cell enhances the expression
of these genes. In addition, SutA generally shifts the gene expression profile away
from genes involved in primary metabolism and toward those involved in cellular
maintenance and secondary metabolisms.
Chapter 3 describes our investigations into the physical interaction between SutA and
RNApolymerase. Because the primary amino acid sequence of SutA does notmatch
any characterized proteins or domains, nothing was known about its mechanism
of transcriptional regulation. We undertook a series of in vitro experiments to
3characterize the structure of SutA and the nature of its binding to RNA polymerase.
Through chemical cross-linking and protein foot-printing, we find evidence that
SutA binds the   lobe 1 and  ’ clamp domains of RNA polymerase and, through
this interaction, may elicit a conformational change of RNApolymerase. We suggest
how this function may explain the physiological e ects described in Chapter 2.
Chapter 4 describes the adaptation of the cell-selective BONCAT method for the
study of heterogeneousP. aeruginosa biofilms. We take advantage of phenotypic dif-
ferences between biofilm cells to restrict BONCAT labeling to an antibiotic-tolerant
subpopulation. We characterize our ability to selectively enrich and identify proteins
synthesized by this subpopoluation. We then determine the dynamic proteomic re-
sponse of these cells to antibiotic challenge with the clinical antibiotic ciprofloxacin,
and place the measured proteomic changes into biological context.
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